Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice
Christer Baeck(Universitätsklinikum Aachen), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum), Felix Heymann(Universitätsklinikum Aachen), Dirk Eulberg(Noxxon Pharma (Germany)), Matthias Bartneck(DWI – Leibniz Institute for Interactive Materials), Viktor Fech(Universitätsklinikum Aachen), Kanishka Hittatiya(University of Bonn), Tom Luedde(Düsseldorf University Hospital), Xiao Wei(Universitätsklinikum Aachen), Nikolaus Gaßler(Ernst Abbe University of Applied Sciences Jena)
Cited by 271
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k